HROW Harrow Health Inc
Company Analysis
Latest News
🟢 Harrow Health Inc is trading 5.3% up today as VERKAZIA relaunch rally continues
Harrow Health Inc is trading at $39.65 (up 5.3%) as the U.S. relaunch of its VERKAZIA ophthalmic treatment continues to fuel a sharp multi-day advance. •...
🟢 Harrow Health Inc is trading 5.14% up today as VERKAZIA relaunch fuels extended rally
Harrow Health Inc is trading 5.14% up today at $39.59, extending a significant rally that began on June 10. • The primary catalyst for the move is the...
🟢 Harrow Health Inc is trading 5.0% up today as VERKAZIA relaunch fuels extended rally
Harrow Health Inc is trading 5.0% up now at $37.70, extending its sharp rally from June 10 after the re-launch of its prescriptive VKC eye treatment, VERKAZIA,...
🟢 Harrow Health Inc is trading 10.25% up today on VERKAZIA eye treatment re-launch
Harrow Health Inc is trading at $36.89 (+10.25%) after the re-launch of its prescriptive VKC eye treatment, VERKAZIA, sparked renewed investor optimism. • The...
🟢 Harrow Health Inc is trading 7% up today on VERKAZIA eye treatment re-launch
Harrow Health Inc is trading 7% up at $35.81 following the re-launch of its prescriptive VKC eye treatment, VERKAZIA, which has sparked renewed investor...
🟢 Harrow Health Inc is trading 6.6% higher after announcing the re-launch of its VKC treatment, VERKAZIA®
Harrow Health Inc is trading 6.6% higher at $35.65 after the company announced the re-launch of VERKAZIA®, a prescription therapy for the allergic eye disease...
🟢 Harrow Health Inc is trading 5.5% up as new investor presentation highlights growth outlook
Harrow Health Inc is trading at $35.15 (5.5% up) after the company provided a fresh business outlook to investors. • On June 3, the company released a new...